Acute Lymphoblastic Leukemia (ALL)

First line Treatment of Children with ALL and Management of Aspararginase -Associated Hypersensitivity - Insights from the US

Pediatric and pediatric-inspired regimens in AYA/adult patients with ALL: Efficacy, safety and practical insights – A US perspective

A clinical perspective on premedication and therapeutic drug monitoring (TDM) in the

ALL AIEOP-BFM trials

Treatment of AYA/adult patients

with ALL: focus on the role of asparaginase

Acute Myeloid Leukemia (AML)

Taking aim at IDH1 mutations to improve outcomes in AML

How to test for, and treat, mIDH1 aml in patients’ ineligible

for intensive chemotherapy: from laboratory to clinical practice

24OV0924WA